The FDA is holding a public meeting on September 27, 2016 to get input from patients who have received organ transplants, their caregivers, and advocates about their conditions and treatments. The meeting will have a morning session for a facilitated patient discussion and an afternoon scientific discussion. It will take place at the FDA's White Oak Campus in Silver Spring, Maryland, and people can attend in person, watch the live webcast, or submit comments through the FDA's website.

1. U.S. Food and Drug Administration (FDA)
PATIENT-FOCUSED
DRUG DEVELOPMENT
PATIENTS WHO HAVE RECEIVED AN
ORGAN TRANSPLANT
Attention patients!
(Caretakers and advocates too)
FDA WANTS TO
HEAR FROM YOU ABOUT
YOUR CONDITION AND
YOUR TREATMENTS
YOU CAN CONTRIBUTE IN MANY WAYS:
Attend the public meeting in person
Watch the live meeting webcast
Share comments through our website
FDA PUBLIC MEETING
DATE:
September 27, 2016
TIME:
9 a.m. to 5 p.m.
Morning session will be a facilitated patient
discussion, followed by a scientific discussion in
the afternoon.
LOCATION:
FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Great Room
Silver Spring, MD 20993
FOR MORE INFORMATION AND TO REGISTER
https://organtransplantpfdd.eventbrite.com
or call (240) 402-6525
Registration closes on September 20th
, 2016